Editas Medicine (EDIT) EPS (Basic) (2015 - 2025)
Editas Medicine (EDIT) posted quarterly EPS (Basic) of -$0.28 for Q3 2025, up 62.99% year-over-year from -$0.17 in Q3 2024, and up 54.71% quarter-over-quarter from -$0.62 in Q2 2025.
Powered by 
Analysis
Editas Medicine (EDIT) EPS (Basic) (2015 - 2025) Analysis & Trends
Editas Medicine (EDIT) has reported EPS (Basic) for 11 consecutive years, with -$0.28 the latest figure, recorded in Q3 2025.
- In Q3 2025, EPS (Basic) rose 62.99% year-over-year to -$0.28; the TTM figure through Dec 2025 stood at -$1.73 (up 40.9% YoY), while the FY2024 annual figure was -$7.6, down 20.28% from the prior year.
- EPS (Basic) climbed to -$0.28 in Q3 2025 per EDIT's latest filing, from -$0.62 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.28 in Q3 2025 and bottomed at -$58.48 in Q1 2022.
- Historically, EPS (Basic) has averaged -$6.39 across 5 years, with a median of -$0.95 in 2025.
- Annual changes were most pronounced in 2022 — EPS (Basic) slumped 3755.5% — and 2023, when it jumped 92.97%.
- Editas Medicine's EPS (Basic) stood at -$0.5 in 2021, then tumbled by 69.01% to -$0.84 in 2022, then surged by 65.35% to -$0.29 in 2023, then sank by 89.62% to -$0.55 in 2024, then soared by 49.66% to -$0.28 in 2025.
- Business Quant data shows EDIT's EPS (Basic) at -$0.28 in Q3 2025, -$0.62 in Q2 2025, and -$0.95 in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -3.06 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.18 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.06 |
| 10 | Editas Medicine | 287.84 Mn | 141.19 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -0.28 |
| Jun 30, 2025 | -0.61 |
| Mar 31, 2025 | -0.91 |
| Dec 31, 2024 | -0.55 |
| Sep 30, 2024 | -0.75 |
| Jun 30, 2024 | -0.82 |
| Mar 31, 2024 | -0.76 |
| Dec 31, 2023 | -0.25 |
| Sep 30, 2023 | -0.55 |
| Jun 30, 2023 | -0.56 |
| Mar 31, 2023 | -0.69 |
| Dec 31, 2022 | -0.88 |
| Sep 30, 2022 | -0.81 |
| Jun 30, 2022 | -0.78 |
| Mar 31, 2022 | -0.73 |
| Dec 31, 2021 | -0.61 |
| Sep 30, 2021 | -0.57 |
| Jun 30, 2021 | -0.81 |
| Mar 31, 2021 | -0.86 |
| Dec 31, 2020 | -1.07 |